Table 2.

Anticoagulation Control for the Entire Cohort using an INR range of 2–3 (PTTR)

	Mean(SD)
Number of Patients	115
Number of Visits	4902
Total Follow Up (months)*	624.5
Follow Up months/patient	5.4 ± 4.8
Number of Visits/patient/month	1.4 ± 0.96
Anticoagulation control for INR Range of 2–3
Percent Time Below Range	41.6 ± 28.4
Percent In Range	42.9 ± 22.5
Percent Time Above Range	15.8 ± 13.9
Number of patients based on PTTR achieved for INR range 2–3	N (%)
PTTR <50% in range	67 (58.3%)
PTTR ≥50–60% in range	25 (21.7%)
PTTR ≥60% in range	23 (20.0%)

^*Follow up time is designated as time to thromboembolism, hemorrhage, death, transplant, withdrawal or end of study (1-year)